Business
Press Release Apr 15 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 15, 2023, titled "Zydus receives final approval from the USFDA for Isoproterenol Hydrochloride Injection".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 15, 2023, titled \"Zydus receives final approval from the USFDA for Isoproterenol Hydrochloride Injection\". View Attachment","length":351,"tagName":"div"}]